BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 8828788)

  • 21. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
    von Segesser LK; Turina M
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
    Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
    J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
    Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
    Wagner WR; Johnson PC; Thompson KA; Marrone GC
    Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased platelet activity in patients with isolated coronary artery ectasia.
    Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
    Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
    Usui A; Hiroura M; Kawamura M; Hibi M; Yoshida K; Murakami F; Tomita Y; Ooshima H; Murase M
    Ann Thorac Surg; 1996 Nov; 62(5):1404-11. PubMed ID: 8893576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
    Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
    Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
    Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.